Pharmacogenetic Cinical Decision Support Service für den schweizer Gesundheitsmarkt.

The projected PGCDSS service analyses the individual pharmacogenetic data and warns the physician in case of critical drug prescriptions.

Steckbrief

  • Departement BFH | Technik und Informatik
  • Forschungsschwerpunkt Mobile Informationsgesellschaft
  • Forschungsfeld Medizininformatik
  • Förderorganisation Gebert Rüf Stiftung
  • Laufzeit (geplant) 01.09.2018 - 30.06.2020
  • Projektleitung Murat Sariyar
  • Schlüsselwörter Pharmakogenetik, Clinical Decision Support, Medizininformatik, Spin-Off

Ausgangslage

Pharmacogenetics is relevant for almost every physician prescribing drugs; the bandwidth of pharmacogenetically relevant drugs ranges from highly specialised anti-cancer medications to very common drugs like codeine. We will provide a PGCDSS that can easily be integrated with the different IT systems of the healthcare providers. Furthermore, our suggested solution can be seamlessly integrated into the physicians’ prescription workflow and thus has low adaptation costs.

Ziel

The aim of our project is a release candidate of a pharmacogenetic clinical decision support service (PGCDSS).

Kernkompetenzen

Genetik, Pharmakogenetik, Bioinformatik, Clinical Decision Support.